Conmed (CNMD) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Leerink Partners Downgrades CONMED (CNMD) to Market Perform
July 28, 2016 7:17 AM EDTLeerink Partners downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $47.00 (from $56.00).
Analyst Richard Newitter commented, "While we are encouraged by Airseal (Surgiquest) outperformance in the qtr, CNMD's organic revenue growth again missed expectations--on weak US ortho capital... More
